Arthrofibrosis is a very prevalent debilitating complication of routine total knee arthroplasty. Our laboratory develops mechanism-based strategies for (i) treatment of arthrofibrosis, (ii) early intervention when the disease process is initiated, and (iii) identification of novel biomarkers that permit the monitoring of disease progression. We will address a major knowledge gap by addressing the central hypothesis that arthrofibrosis is initiated in vivo by local alterations in inflammation-related tissue repair processes after joint surgery. We propose that inflammatory processes modulate formation of mechano-protective transient connective tissues and that deregulation of normal joint tissue healing results in alterations in the growth, differentiation and activity of (proto)myofibroblasts that may emerge from the perivascular compartment of synovial tissues. To understand the mechanisms contributing to arthrofibrosis, we will analyze (i) the pathologic roles of inflammatory processes in a rabbit model for arthrofibrosis (Aim 1); and (ii) mechanisms of myofibroblastogenesis that are deregulated during arthrofibrosis by molecular analyses of biopsies and primary cell cultures from patients undergoing revision TKAs for arthrofibrosis, as well as established in vitro models for myofibroblast proliferation and differentiation in culture, as well as co-culture models with mast cells involved in the initial inflammatory response during tissue repair (Aim 2). The key deliverables of this proposal are translational innovation (Aim 1) by establishing (i) the mechanistic role of inflammation in arthrofibrosis and (ii) characterization of the potential efficacy of anti-inflammatory drugs to mitigate or reverse disease progression. Furthermore, this study is conceptually innovative (Aim 2) by establishing (iii) cell structure-linked kinase-mediated signaling pathways and gene regulatory networks that mediate myofibroblast differentiation in joint tissues, and (iv) functional consequences of inhibiting key regulatory proteins that drive the intrinsic ability of fibroblasts to convert to myofibroblasts.

Public Health Relevance

Arthrofibrosis occurs frequently as a result of knee replacement procedures, but the reasons for joint stiffening have not been sufficiently explored, even though much progress has been made on fibrosis in non- musculoskeletal tissues (e.g., lung, kidney, heart). Our work will investigate two major ideas related to the formation of the extensive build-up of connective tissue that occurs during joint stiffening. First, we are considering the role of the immune system and inflammation-related mechanisms that are activated within two weeks of joint injury (e.g., due to surgery or trauma). This concept will be tested in a live rabbit model in which we treat animals with non-steroidal anti-inflammatory drugs (NSAIDs) during progression of arthrofibrosis. Second, we are investigating the idea that joint stiffening is in part linked to defects in the growth, differentiation and activity of tissue repair cells that may be recruited from adult mesenchymal stem cells residing around blood vessels and that interact with inflammation-related cells. These studies will uncover new fibrosis-related molecular pathways that could support new mechanism-based pharmacological therapies for arthrofibrosis. The main achievements of this study are biomedically relevant, because there is currently no approved effective pharmacological therapy to either prevent or treat joint stiffening. Furthermore, our studies move the boundary of knowledge by generating a highly detailed molecular blueprint of how repair cells can become error-prone in their responses to the physiological environment of the healing joint.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Washabaugh, Charles H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Morrey, Mark E; Sanchez-Sotelo, Joaquin; Lewallen, Eric A et al. (2018) Intra-articular injection of a substance P inhibitor affects gene expression in a joint contracture model. J Cell Biochem 119:1326-1336
Lewallen, Eric A; Salib, Christopher G; Trousdale, William H et al. (2018) Molecular pathology of total knee arthroplasty instability defined by RNA-seq. Genomics 110:247-256
Arsoy, Diren; Salib, Christopher G; Trousdale, William H et al. (2018) Joint contracture is reduced by intra-articular implantation of rosiglitazone-loaded hydrogels in a rabbit model of arthrofibrosis. J Orthop Res :
Reina, Nicolas; Trousdale, William H; Salib, Christopher G et al. (2018) Validation of a dynamic joint contracture measuring device in a live rabbit model of arthrofibrosis. J Orthop Res :
Trousdale, William H; Salib, Christopher G; Reina, Nicolas et al. (2018) A Drug Eluting Scaffold for the Treatment of Arthrofibrosis. Tissue Eng Part C Methods 24:514-523
Salib, Christopher G; Lewallen, Eric A; Paradise, Christopher R et al. (2018) Molecular pathology of adverse local tissue reaction caused by metal-on-metal implants defined by RNA-seq. Genomics :
Riester, Scott M; Lin, Yang; Wang, Wei et al. (2018) RNA sequencing identifies gene regulatory networks controlling extracellular matrix synthesis in intervertebral disk tissues. J Orthop Res 36:1356-1369
van Wijnen, Andre J; Abdel, Matthew P (2017) Vitamin-D Supplementation: A Low-Risk, High-Gain Therapy to Prevent PJI?: Commentary on an article by Vishal Hegde, MD, et al.: ""Single-Dose, Preoperative Vitamin-D Supplementation Decreases Infection in a Mouse Model of Periprosthetic Joint Infection"". J Bone Joint Surg Am 99:e110